摘要 |
The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R<SUP>1</SUP>, R<SUP>a</SUP>, R<SUP>8</SUP>, R<SUP>2</SUP>, R<SUP>3 </SUP>and R<SUP>4 </SUP>are as defined in the specification, in the preparation of a medicament for the treatment of C-C chemokine mediated conditions. Novel compounds of formula (I) and pharmaceutical compositions containing them are also described and claimed.
|